About Us
About Us Submenu
Mission
By integrating collaborative genomics research into cancer care, we advance precision health and deliver hope for everyone.
Vision
To make precision cancer genomic medicine available for all patients.
The BC Cancer Personalized OncoGenomics (POG) Program is a patient-focused research initiative that explores how whole genome and transcriptome analysis can be integrated into the care of people in B.C. with advanced cancers. The program is co-led by Marco Marra, Distinguished Scientist at the BC Cancer Research Institute and UBC Killam Professor, and Janessa Laskin, a medical oncologist at BC Cancer. POG brings together oncologists, pathologists, researchers, and technical experts to better understand cancer and improve patient care through precision oncology.
As a world-leading research program, POG uses extensive genomic analysis to study the genetic changes that drive cancer growth, spread, evolution, and response to treatment. By combining genomic, transcriptomic, clinical, and treatment data, the program creates a rich resource for understanding why some therapies work for certain patients while others do not.
Findings from the first 570 patients were published in the April 2020 issue of Nature Cancer and featured on its cover. The study demonstrated how cancer treatments can shape tumour genomes and highlighted the potential of precision oncology to offer more effective treatment options for patients with advanced cancers.
Established in 2025, the POG Patient Working Group was created to bring patient perspectives directly into the program. Its first initiative is a video series featuring stories and insights from both patients and members of the POG team. Through these personal experiences, viewers gain a deeper understanding of personalized cancer care and its impact on patients’ lives. This work was made possible through support from the BC Cancer Foundation.
A Word From Our Team
Behind every discovery is a team of dedicated clinicians, researchers, scientists, genomic analysts, and staff working together to advance precision oncology. Hear from members of the POG team as they share our mission, the impact of our work, and our commitment to improving cancer care through research.